Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update
Novo Nordisk Foundation · Health Solutions (Sweden) · +1 more institution
Indexed incrossrefpubmed
Abstract
Clinically administered cells, so far showing no generalizable safety concerns.
Citation impact
144
total citations
- FWCI
- 88.74
- Percentile
- 100%
- References
- 191
Citations per year
Authors
3Topics & keywords
Topics
Keywords
- Biology
- Induced pluripotent stem cell
- Stem cell
- Clinical trial
- Computational biology
- Bioinformatics
- Genetics
- Embryonic stem cell
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.